Han, Xin
University of Michigan · U-M Rogel Cancer Center
3 papers on CoChatORCID 0000-0003-0904-220X
Most cited papers
- Verified
Discovery of MD-224 as a First-in-Class, Highly Potent, and Efficacious Proteolysis Targeting Chimera Murine Double Minute 2 Degrader Capable of Achieving Complete and Durable Tumor Regression
Li, Y., Yang, J., Aguilar, A., McEachern, D., Przybranowski, S., Liu, L., Yang, C.-Y., Wang, M., Han, X., & Wang, S. (2019) · Journal of Medicinal Chemistry
Protein Degradation and InhibitorsCancer-related Molecular Pathways
Cited by 312
- Verified
CD47, a ligand for the macrophage fusion receptor, participates in macrophage multinucleation
Han, X., Sterling, H., Chen, Y., Saginario, C., Brown, E. J., Frazier, W. A., Lindberg, F. P., & Vignery, A. (2000) · Journal of Biological Chemistry
Phagocytosis and Immune RegulationCellular transport and secretion
Cited by 245
- Verified
Strategies toward Discovery of Potent and Orally Bioavailable Proteolysis Targeting Chimera Degraders of Androgen Receptor for the Treatment of Prostate Cancer
Han, X., Zhao, L., Xiang, W., Qin, C., Miao, B., McEachern, D., Wang, Y., Metwally, H., Wang, L., Matvekas, A., et al. (2021) · Journal of Medicinal Chemistry
Protein Degradation and InhibitorsProstate Cancer Treatment and Research
Cited by 170
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free